Main Pages
Articles for $RYTM
Rhythm Pharmaceuticals Appoints Kim Popovits to Board, Ed Mathers ResignsRhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE ExpansionRhythm Pharmaceuticals Receives FDA Approval for Expanded Indication of IMCIVREE to Treat Acquired Hypothalamic ObesityRhythm Pharmaceuticals Reports EMANATE Trial Results; Substudies Fail Primary Endpoints